Measles-containing-vaccine second-dose (MCV2) immunization coverage in Afghanistan
Afghanistan: Measles-containing-vaccine second-dose (MCV2) immunization coverage was 42.0% in 2025. ◆ Volatile
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Afghanistan, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
Afghanistan recorded 42.0% for measles-containing-vaccine second-dose (mcv2) immunization coverage in 2025.
That represents a change of down 4.5% on the previous year and unchanged over ten years.
Over the whole period, measles-containing-vaccine second-dose (mcv2) immunization coverage in Afghanistan peaked at 46.0% in 2018 and was at its lowest, 0.0%, in 2000.
Afghanistan ranks 182nd of 194 countries on this measure, in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Afghanistan, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 2.0% | — |
| 2005 | 9.0% | +350.0% |
| 2006 | 18.0% | +100.0% |
| 2007 | 4.0% | -77.8% |
| 2008 | 23.0% | +475.0% |
| 2009 | 24.0% | +4.3% |
| 2010 | 29.0% | +20.8% |
| 2011 | 31.0% | +6.9% |
| 2012 | 33.0% | +6.5% |
| 2013 | 38.0% | +15.2% |
| 2014 | 44.0% | +15.8% |
| 2015 | 42.0% | -4.5% |
| 2016 | 40.0% | -4.8% |
| 2017 | 38.0% | -5.0% |
| 2018 | 46.0% | +21.1% |
| 2019 | 37.0% | -19.6% |
| 2020 | 38.0% | +2.7% |
| 2021 | 37.0% | -2.6% |
| 2022 | 42.0% | +13.5% |
| 2023 | 42.0% | +0.0% |
| 2024 | 44.0% | +4.8% |
| 2025 | 42.0% | -4.5% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 8.0% | 0.0% | 24.0% | 10 |
| 2010s | 37.8% | 29.0% | 46.0% | 10 |
| 2020s | 40.8% | 37.0% | 44.0% | 6 |
Countries ranked near Afghanistan
- 179 Argentina 46.0% compare
- 179 Angola 46.0% compare
- 181 Mozambique 44.0% compare
- 183 Madagascar 41.0% compare
- 184 Vanuatu 40.0% compare
- 185 Yemen 38.0% compare
- 185 Venezuela, Bolivarian Republic of 38.0% compare
More health data for Afghanistan
- Un projection of annual infant deaths, annual growth rate -1.45 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.03 % change on previous year (2090)
- Heat deaths vs projected death rates 812.4 (2090)
- Un projection of annual infant deaths 14,735 (2100)
- Population ages 15-64, male, annual growth rate 3.47 % change on previous year (2025)
- Population ages 15-64, male, per unit of GDP 0.0007 units per US$ of GDP (2024)
- Population ages 15-64, male, per capita 0.2772 units per person (2025)
- Population ages 15-64, total, annual growth rate 3.37 % change on previous year (2025)
- Population ages 15-64, total, per unit of GDP 0.0013 units per US$ of GDP (2024)
- Population ages 15-64, total, per capita 0.5501 units per person (2025)
Frequently asked questions
- What is measles-containing-vaccine second-dose (mcv2) immunization coverage in Afghanistan?
- Measles-containing-vaccine second-dose (mcv2) immunization coverage in Afghanistan was 42.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Afghanistan?
- The highest recorded value was 46.0% in 2018.
- What is the lowest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Afghanistan?
- The lowest recorded value was 0.0% in 2000.
- How does Afghanistan rank for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Afghanistan ranks 182nd out of 194 countries with data for 2025.
- Is measles-containing-vaccine second-dose (mcv2) immunization coverage rising or falling in Afghanistan?
- Over the last ten years it is unchanged. The long-run trend across the full record is volatile.
- Where does this Afghanistan data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).